Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa B Bland

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Clinical Genitourinary Cancer|January 24, 2007
Parenteral estrogens for prostate cancer: can a new route of administration overcome old toxicities?Jennifer L Lycette, Lisa B Bland, Mark Garzotto, et al.
Clinical Prostate Cancer|March 26, 2004
Weekly docetaxel in elderly patients with prostate cancer: efficacy and toxicity in patients at least 70 years of age compared with patients younger than 70 yearsTomasz M Beer, William Berry, Emily M Wersinger, et al.
The Journal of Urology|November 13, 2004
Prognostic value of anemia in newly diagnosed metastatic prostate cancer: a multivariate analysis of southwest oncology group study 8894Tomasz M Beer, Catherine M Tangen, Lisa B Bland, et al.
Cancer|June 29, 2006
The prognostic value of hemoglobin change after initiating androgen-deprivation therapy for newly diagnosed metastatic prostate cancer: A multivariate analysis of Southwest Oncology Group Study 8894Tomasz M Beer, Catherine M Tangen, Lisa B Bland, et al.
Cancer|January 11, 2005
Phase II study of transdermal estradiol in androgen-independent prostate carcinomaLisa B Bland, Mark Garzotto, Thomas G DeLoughery, et al.
Journal of Lipid Research|November 22, 2005
Effects of transdermal estrogen on levels of lipids, lipase activity, and inflammatory markers in men with prostate cancerJonathan Q Purnell, Lisa B Bland, Mark Garzotto, et al.
The Journal of Urology|January 13, 2006
Testosterone loss and estradiol administration modify memory in menTomasz M Beer, Lisa B Bland, Joseph R Bussiere, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Clinical Genitourinary Cancer|January 24, 2007
Parenteral estrogens for prostate cancer: can a new route of administration overcome old toxicities?Jennifer L Lycette, Lisa B Bland, Mark Garzotto, et al.
Clinical Prostate Cancer|March 26, 2004
Weekly docetaxel in elderly patients with prostate cancer: efficacy and toxicity in patients at least 70 years of age compared with patients younger than 70 yearsTomasz M Beer, William Berry, Emily M Wersinger, et al.
The Journal of Urology|November 13, 2004
Prognostic value of anemia in newly diagnosed metastatic prostate cancer: a multivariate analysis of southwest oncology group study 8894Tomasz M Beer, Catherine M Tangen, Lisa B Bland, et al.
Cancer|June 29, 2006
The prognostic value of hemoglobin change after initiating androgen-deprivation therapy for newly diagnosed metastatic prostate cancer: A multivariate analysis of Southwest Oncology Group Study 8894Tomasz M Beer, Catherine M Tangen, Lisa B Bland, et al.
Cancer|January 11, 2005
Phase II study of transdermal estradiol in androgen-independent prostate carcinomaLisa B Bland, Mark Garzotto, Thomas G DeLoughery, et al.
Journal of Lipid Research|November 22, 2005
Effects of transdermal estrogen on levels of lipids, lipase activity, and inflammatory markers in men with prostate cancerJonathan Q Purnell, Lisa B Bland, Mark Garzotto, et al.
The Journal of Urology|January 13, 2006
Testosterone loss and estradiol administration modify memory in menTomasz M Beer, Lisa B Bland, Joseph R Bussiere, et al.
Pageof 1